{"schema_version":"secwatch.filing_event.v1","accession":"0001731122-21-001568","form_type":"8-K","ticker":"AVXL","cik":"0001314052","company_name":"ANAVEX LIFE SCIENCES CORP.","filed_at":"2021-09-27T23:59:59+00:00","discovered_at":"2026-05-14T18:04:17.585534+00:00","generated_at":"2026-06-29T01:13:33.583552+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Anavex Life Sciences uplists to Nasdaq Global Select Market, ticker AVXL unchanged","bullets":["Common stock approved for listing on Nasdaq Global Select Market, effective September 27, 2021.","Previously traded on Nasdaq Capital Market; ticker symbol remains AVXL.","Uplisting reflects meeting Nasdaq Global Select Market's higher financial and liquidity requirements."],"urls":{"canonical":"https://secwatch.observer/filing/0001731122-21-001568","json":"https://secwatch.observer/filing/0001731122-21-001568.json","markdown":"https://secwatch.observer/filing/0001731122-21-001568.md","text":"https://secwatch.observer/filing/0001731122-21-001568.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1314052/000173112221001568/0001731122-21-001568-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1314052/000173112221001568/e3115_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T01:13:33.583552+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}